BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17213812)

  • 1. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
    Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
    Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and modulation of PTEN activity.
    Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
    Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression.
    Lindsay Y; McCoull D; Davidson L; Leslie NR; Fairservice A; Gray A; Lucocq J; Downes CP
    J Cell Sci; 2006 Dec; 119(Pt 24):5160-8. PubMed ID: 17158918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
    Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
    Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear import and retention domains in the amino terminus of RECQL4.
    Burks LM; Yin J; Plon SE
    Gene; 2007 Apr; 391(1-2):26-38. PubMed ID: 17250975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade.
    Liu JL; Mao Z; LaFortune TA; Alonso MM; Gallick GE; Fueyo J; Yung WK
    Cancer Res; 2007 Nov; 67(22):11054-63. PubMed ID: 18006852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis.
    Chung JH; Eng C
    Cancer Res; 2005 Sep; 65(18):8096-100. PubMed ID: 16166282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional dissection of PTEN N-terminus: implications in PTEN subcellular targeting and tumor suppressor activity.
    Gil A; Rodríguez-Escudero I; Stumpf M; Molina M; Cid VJ; Pulido R
    PLoS One; 2015; 10(4):e0119287. PubMed ID: 25875300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutant form of PTEN linked to autism.
    Redfern RE; Daou MC; Li L; Munson M; Gericke A; Ross AH
    Protein Sci; 2010 Oct; 19(10):1948-56. PubMed ID: 20718038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avian Reovirus Protein p17 Functions as a Nucleoporin Tpr Suppressor Leading to Activation of p53, p21 and PTEN and Inactivation of PI3K/AKT/mTOR and ERK Signaling Pathways.
    Huang WR; Chiu HC; Liao TL; Chuang KP; Shih WL; Liu HJ
    PLoS One; 2015; 10(8):e0133699. PubMed ID: 26244501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase activity of nuclear PTEN is required for CDX2-mediated intestinal differentiation of gastric carcinoma.
    Semba S; Satake S; Matsushita M; Yokozaki H
    Cancer Lett; 2009 Feb; 274(1):143-50. PubMed ID: 18996641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress.
    Maccario H; Perera NM; Gray A; Downes CP; Leslie NR
    J Biol Chem; 2010 Apr; 285(17):12620-8. PubMed ID: 20177066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney.
    Kim D; Dressler GR
    Dev Biol; 2007 Jul; 307(2):290-9. PubMed ID: 17540362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
    Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN inhibits BMI1 function independently of its phosphatase activity.
    Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
    Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
    Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane.
    Vazquez F; Matsuoka S; Sellers WR; Yanagida T; Ueda M; Devreotes PN
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3633-8. PubMed ID: 16537447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.